These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

519 related items for PubMed ID: 26313360

  • 1. Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy.
    Gaur S, Wen Y, Song JH, Parikh NU, Mangala LS, Blessing AM, Ivan C, Wu SY, Varkaris A, Shi Y, Lopez-Berestein G, Frigo DE, Sood AK, Gallick GE.
    Oncotarget; 2015 Oct 06; 6(30):29161-77. PubMed ID: 26313360
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer.
    Chen WY, Liu SY, Chang YS, Yin JJ, Yeh HL, Mouhieddine TH, Hadadeh O, Abou-Kheir W, Liu YN.
    Oncotarget; 2015 Jan 01; 6(1):441-57. PubMed ID: 25436980
    [Abstract] [Full Text] [Related]

  • 3. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
    Saini S, Majid S, Yamamura S, Tabatabai L, Suh SO, Shahryari V, Chen Y, Deng G, Tanaka Y, Dahiya R.
    Clin Cancer Res; 2011 Aug 15; 17(16):5287-98. PubMed ID: 21159887
    [Abstract] [Full Text] [Related]

  • 4. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
    Deng X, Cao M, Zhang J, Hu K, Yin Z, Zhou Z, Xiao X, Yang Y, Sheng W, Wu Y, Zeng Y.
    Biomaterials; 2014 May 15; 35(14):4333-44. PubMed ID: 24565525
    [Abstract] [Full Text] [Related]

  • 5. Methylation-induced silencing of miR-34a enhances chemoresistance by directly upregulating ATG4B-induced autophagy through AMPK/mTOR pathway in prostate cancer.
    Liao H, Xiao Y, Hu Y, Xiao Y, Yin Z, Liu L, Kang X, Chen Y.
    Oncol Rep; 2016 Jan 15; 35(1):64-72. PubMed ID: 26499184
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
    Colden M, Dar AA, Saini S, Dahiya PV, Shahryari V, Yamamura S, Tanaka Y, Stein G, Dahiya R, Majid S.
    Cell Death Dis; 2017 Jan 26; 8(1):e2572. PubMed ID: 28125091
    [Abstract] [Full Text] [Related]

  • 7. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.
    Huang S, Wa Q, Pan J, Peng X, Ren D, Huang Y, Chen X, Tang Y.
    J Exp Clin Cancer Res; 2017 Dec 04; 36(1):173. PubMed ID: 29202848
    [Abstract] [Full Text] [Related]

  • 8. Epidermal growth factor receptor signaling promotes metastatic prostate cancer through microRNA-96-mediated downregulation of the tumor suppressor ETV6.
    Tsai YC, Chen WY, Siu MK, Tsai HY, Yin JJ, Huang J, Liu YN.
    Cancer Lett; 2017 Jan 01; 384():1-8. PubMed ID: 27746161
    [Abstract] [Full Text] [Related]

  • 9. Kallistatin induces breast cancer cell apoptosis and autophagy by modulating Wnt signaling and microRNA synthesis.
    Li P, Guo Y, Bledsoe G, Yang Z, Chao L, Chao J.
    Exp Cell Res; 2016 Jan 15; 340(2):305-14. PubMed ID: 26790955
    [Abstract] [Full Text] [Related]

  • 10. miR-27b and miR-34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1.
    Zhang G, Tian X, Li Y, Wang Z, Li X, Zhu C.
    Biomed Pharmacother; 2018 Jan 15; 97():736-744. PubMed ID: 29102917
    [Abstract] [Full Text] [Related]

  • 11. Bone targeted miRNA delivery system for miR-34a with enhanced anti-tumor efficacy to bone-associated metastatic breast cancer.
    Han TY, Hou LS, Li JX, Huan ML, Zhou SY, Zhang BL.
    Int J Pharm; 2023 Mar 25; 635():122755. PubMed ID: 36801480
    [Abstract] [Full Text] [Related]

  • 12. Modulation of miR-34a in curcumin-induced antiproliferation of prostate cancer cells.
    Zhu M, Zheng Z, Huang J, Ma X, Huang C, Wu R, Li X, Liang Z, Deng F, Wu J, Geng S, Xie C, Zhong C.
    J Cell Biochem; 2019 Sep 25; 120(9):15616-15624. PubMed ID: 31042325
    [Abstract] [Full Text] [Related]

  • 13. miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression.
    Chakravarthi BVSK, Chandrashekar DS, Agarwal S, Balasubramanya SAH, Pathi SS, Goswami MT, Jing X, Wang R, Mehra R, Asangani IA, Chinnaiyan AM, Manne U, Sonpavde G, Netto GJ, Gordetsky J, Varambally S.
    Mol Cancer Res; 2018 Jul 25; 16(7):1125-1137. PubMed ID: 29025958
    [Abstract] [Full Text] [Related]

  • 14. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
    Fujita Y, Kojima K, Hamada N, Ohhashi R, Akao Y, Nozawa Y, Deguchi T, Ito M.
    Biochem Biophys Res Commun; 2008 Dec 05; 377(1):114-9. PubMed ID: 18834855
    [Abstract] [Full Text] [Related]

  • 15. Cationic microRNA-delivering nanovectors with bifunctional peptides for efficient treatment of PANC-1 xenograft model.
    Hu QL, Jiang QY, Jin X, Shen J, Wang K, Li YB, Xu FJ, Tang GP, Li ZH.
    Biomaterials; 2013 Mar 05; 34(9):2265-76. PubMed ID: 23298779
    [Abstract] [Full Text] [Related]

  • 16. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
    Cai C, Chen QB, Han ZD, Zhang YQ, He HC, Chen JH, Chen YR, Yang SB, Wu YD, Zeng YR, Qin GQ, Liang YX, Dai QS, Jiang FN, Wu SL, Zeng GH, Zhong WD, Wu CL.
    Clin Cancer Res; 2015 Nov 01; 21(21):4922-34. PubMed ID: 26080838
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy.
    Zhai H, Fesler A, Ba Y, Wu S, Ju J.
    Oncotarget; 2015 Aug 14; 6(23):19735-46. PubMed ID: 25980495
    [Abstract] [Full Text] [Related]

  • 18. In bone metastasis miR-34a-5p absence inversely correlates with Met expression, while Met oncogene is unaffected by miR-34a-5p in non-metastatic and metastatic breast carcinomas.
    Maroni P, Puglisi R, Mattia G, Carè A, Matteucci E, Bendinelli P, Desiderio MA.
    Carcinogenesis; 2017 May 01; 38(5):492-503. PubMed ID: 28334277
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer.
    Taniguchi K, Sugito N, Kumazaki M, Shinohara H, Yamada N, Nakagawa Y, Ito Y, Otsuki Y, Uno B, Uchiyama K, Akao Y.
    Cancer Lett; 2015 Jul 10; 363(1):17-27. PubMed ID: 25818238
    [Abstract] [Full Text] [Related]

  • 20. Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and Promises.
    Li WJ, Wang Y, Liu X, Wu S, Wang M, Turowski SG, Spernyak JA, Tracz A, Abdelaal AM, Sudarshan K, Puzanov I, Chatta G, Kasinski AL, Tang DG.
    Int J Mol Sci; 2024 Feb 09; 25(4):. PubMed ID: 38396800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.